Summary:
This podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about formulation and physical approaches to achieve targeted brain delivery. The panelists discuss challenges and updates, patient acceptability and recent approvals for a variety of approaches including:
- Nose-to-brain delivery
- Introcerebroventricular injections
- Blood-brain-barrier disruption via excipients
- Implantable approaches
- Combinations
To learn more about the PODD conference, please visit Drug-Delivery.org.
Moderators
Alexander Josowitz, PhD
Senior Scientist, Formulations Development
Regeneron
Panelists
Darren Reid, PhD
Director, Process Development
Amgen
Shankar Swaminathan, PhD
Team Lead, Drug Product Development, Astellas Institute for Regenerative Medicine
Astellas Pharma
Bill Loudon, MD, PhD
VP NeuroScience
Bionaut Labs
Lisa Shafer, PhD
Global Head of Product Development and Reg CMC, Medical Devices and Packaging
Biogen
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.